result better expect driven top-lin sg
encourag beat coupl ep guidanc rais
growth acceler cadenc look forward see revenu guidanc
achiev result key product categori boost growth
includ low risk tavr mazor/spin pull micra brain therapi
new devic surgic robot reiter buy rate
share think today result support view continu drive
msd growth near term potenti acceler
given pipelin contribut increas ep forecast factor cadenc
slightli higher organ growth assumpt lower interest tax drag think
growth mitg rtg cov help drive growth
see acceler next year consensu increas price target
base ep estim still discount peer
fy revenu guidanc reiter organ ep rang rais
remind expect revenu growth acceler vs driven major
product launch also begin lap product headwind lvad dcb af
servic replac help growth improv long list
product await approv launch earli includ micra av
interstim micro minim diamond temp rf ablat av fistula dcb
out-performance rtg mitg divis
rtg sale con increas xfx guidanc ldd
growth brain therapi msd specialti lsd growth spine pain
mitg sale con increas xfx guidanc diabet
sale con increas xfx guidanc lsd growth cvg
sale con grew xfx guidanc
valuat still look inexpens vs peer pathway higher growth
trade consensu ep april end compar peer like cy
fy previou price target
base prior ep
trade data key metric
compani account thomson reuter ub estim ub adjust ep state goodwill-rel charg adjust abnorm econom item analyst
judgement valuat base averag share price year base share price estimate
report prepar ub secur llc analyst certif requir disclosur begin
page ub seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
look forward reiter guidanc organ growth fx
neg impact ep rang vs prior
con includ roughli neg impact fx
remind expect revenu growth acceler vs driven
major product launch also begin lap headwind optic
increas bp midpoint
increas bp midpoint
increas bp midpoint
competit pressur us
point y/y/ declin half currenc
modest improv
slightli report
convers lrp
mm neg
flat slightli
similar
slight improv y/i
similar rest year
slight improv
valuat method risk statement
price target base ep risk
price target includ slowdown core cardio neuro spine surgic end
market increas competit establish larg cap compani
competit entrant differenti technolog delay key product
approv reject regulatori bodi inabl deliv top-lin growth
meet consensu expect top line miss guidanc consensu
bottom line delay robot launch timelin mitral project
meet expect chang regulatori environ lead longer
lead time higher bar approv
report prepar ub secur llc affili ub ag ub ag subsidiari branch affili
refer herein ub
inform way ub manag conflict maintain independ research product histor
perform inform certain addit disclosur concern ub research recommend pleas visit
www ub com/disclosur figur contain perform chart refer past past perform reliabl
indic futur result addit inform made avail upon request ub secur co limit licens
conduct secur invest consult busi china secur regulatori commiss ub act may act
princip debt secur relat deriv may subject report recommend
final novemb pm gmt ub design certain research depart member deriv
research analyst depart member publish research princip analysi price market
deriv provid inform reason suffici upon base decis enter deriv
transact deriv research analyst co-author research report equiti research analyst economist
deriv research analyst respons deriv invest view forecast and/or recommend
analyst certif research analyst primarili respons content research report whole part
certifi respect secur issuer analyst cover report view express
accur reflect person view secur issuer prepar independ manner
includ respect ub part compens directli indirectli relat
specif recommend view express research analyst research report
fsr mra
fsr mra
fsr mra
stock price expect rise within three month time
rate assign specif catalyst event
stock price expect fall within three month time
rate assign specif catalyst event
ub rate alloc septemb
compani coverag global within rate categori
compani within rate categori invest bank ib servic provid
within past month
compani coverag global within short-term rate categori
compani within short-term rate categori invest bank ib servic provid
within past month
definit forecast stock return fsr defin expect percentag price appreci plu gross dividend
yield next month case yield may base accru dividend market return assumpt
mra defin one-year local market interest rate plu proxi forecast equiti risk
premium review ur stock may flag ur analyst indic stock price target and/or
rate subject possibl chang near term usual respons event may affect invest case
valuat short-term rate reflect expect near-term three month perform stock
reflect chang fundament view invest case equiti price target invest horizon
except special case uk european invest fund rate definit buy posit
factor structur manag perform record discount neutral neutral factor structur
manag perform record discount sell neg factor structur manag perform record
discount band except cbe except standard band may grant invest
review committe irc factor consid irc includ stock volatil credit spread respect
compani debt result stock deem high low risk may subject higher lower band
relat rate except appli identifi compani disclosur tabl relev
